Ferric derisomaltose 1g/10ml solution for injection vials
NHS hospitals in England used £24,462,300 of indicative cost of Ferric derisomaltose 1g/10ml solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 21.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ferric derisomaltose 1g/10ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ferric derisomaltose 1g/10ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £1,077,681 |
| Gloucestershire Hpls Nhs Foundation Trst | £828,347 |
| Cambridge Univ Hosp Nhs Foundation Trust | £820,380 |
| Barkinghavering & Redbridge Hpls Trst | £646,473 |
| North Bristol Nhs Trust | £603,081 |
| Guy's & St Thomas' Nhs Foundation Trust | £601,701 |
| University Hospital Southampton Nhs Ft | £594,437 |
| Northumbria H/Care Nhs Foundation Trust | £535,451 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £533,247 |
| Western Sussex Hospitals Nhs Found Trust | £527,315 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.